semaglutide maker Explainer: What's behind the scramble for semaglutide? Use of new diet drugs
Description
The information provided here is not a substitute for professional medical advice, diagnosis, or treatment
Transitioning between tirzepatide and other GLP-1 medications Users sometimes switch between tirzepatide and semaglutide or other GLP-1 receptor agonists
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates only GLP-1
As a result, procurement teams receive consistent support for audit readiness and internal QA review
In 2021, the FDA approved the semaglutide formulation Wegovy for weight loss, based largely on the STEP trial that demonstrated a 12.4% average loss in body weight over the course of a year [8-9]
